Atlas Trials

Relationship Between FGF19 Overexpression and Disease Prognosis

Clinical trial NCT06938451 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06938451
Sponsor
Beijing Tsinghua Chang Gung Hospital
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Hepatocellular Carcinoma (HCC)
Start date
2025-05-01
Primary completion
2028-12-31
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.